Nexalin Technology (NXL) Competitors $3.16 0.00 (0.00%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NXL vs. TELA, SRTS, ECOR, FONR, GUTS, LNSR, MLSS, MGRM, EDAP, and HYPRShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include TELA Bio (TELA), Sensus Healthcare (SRTS), electroCore (ECOR), FONAR (FONR), Fractyl Health (GUTS), LENSAR (LNSR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. TELA Bio Sensus Healthcare electroCore FONAR Fractyl Health LENSAR Milestone Scientific Monogram Orthopaedics Edap Tms Hyperfine Nexalin Technology (NASDAQ:NXL) and TELA Bio (NASDAQ:TELA) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations. Do insiders and institutionals hold more shares of NXL or TELA? 0.6% of Nexalin Technology shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 24.0% of Nexalin Technology shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community believe in NXL or TELA? TELA Bio received 58 more outperform votes than Nexalin Technology when rated by MarketBeat users. Likewise, 74.68% of users gave TELA Bio an outperform vote while only 50.00% of users gave Nexalin Technology an outperform vote. CompanyUnderperformOutperformNexalin TechnologyOutperform Votes150.00% Underperform Votes150.00% TELA BioOutperform Votes5974.68% Underperform Votes2025.32% Do analysts rate NXL or TELA? Nexalin Technology currently has a consensus price target of $3.00, suggesting a potential downside of 5.06%. TELA Bio has a consensus price target of $9.25, suggesting a potential upside of 243.87%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts clearly believe TELA Bio is more favorable than Nexalin Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, NXL or TELA? Nexalin Technology has higher earnings, but lower revenue than TELA Bio. Nexalin Technology is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$162.08K259.39-$4.65M-$0.64-4.94TELA Bio$58.45M1.81-$46.66M-$1.69-1.59 Does the media refer more to NXL or TELA? In the previous week, Nexalin Technology had 4 more articles in the media than TELA Bio. MarketBeat recorded 4 mentions for Nexalin Technology and 0 mentions for TELA Bio. Nexalin Technology's average media sentiment score of 0.25 beat TELA Bio's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the media. Company Overall Sentiment Nexalin Technology Neutral TELA Bio Neutral Is NXL or TELA more profitable? TELA Bio has a net margin of -60.49% compared to Nexalin Technology's net margin of -3,407.98%. Nexalin Technology's return on equity of -187.59% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-3,407.98% -187.59% -167.21% TELA Bio -60.49%-556.18%-63.13% Which has more risk & volatility, NXL or TELA? Nexalin Technology has a beta of 4.24, suggesting that its stock price is 324% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. SummaryTELA Bio beats Nexalin Technology on 10 of the 18 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyElectromedical equipment IndustryBusiness SectorNASDAQ ExchangeMarket Cap$42.04M$3.58B$7.23B$8.92BDividend YieldN/A1.67%2.31%4.02%P/E Ratio-4.9412.9622.5014.18Price / Sales259.3970.30103.9064.30Price / CashN/A41.1029.1435.97Price / Book7.353.916.194.79Net Income-$4.65M$96.59M$134.52M$225.00M7 Day Performance18.80%3.48%1.26%1.52%1 Month Performance3.27%5.81%5.77%4.88%1 Year Performance605.52%4.35%24.04%20.12% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology1.1974 of 5 stars$3.16flat$3.00-5.1%+602.2%$42.04M$162,078.00-4.943Short Interest ↓Positive NewsGap DownTELATELA Bio2.7734 of 5 stars$2.78-1.1%$9.25+232.7%-61.3%$109.50M$68.65M-1.64120SRTSSensus Healthcare3.3743 of 5 stars$6.38-2.4%$12.50+95.9%+142.1%$104.56M$41.31M11.1940Short Interest ↑ECORelectroCore3.4075 of 5 stars$15.45-6.6%$25.00+61.8%+141.3%$101.28M$23.33M-8.4450Short Interest ↓Positive NewsGap DownFONRFONAR0.9029 of 5 stars$15.13-0.7%N/A-20.9%$95.74M$102.01M10.81480Short Interest ↑GUTSFractyl Health1.7615 of 5 stars$1.95+5.4%$22.00+1,028.2%N/A$93.79M$97,000.00-0.16102Short Interest ↑Positive NewsGap UpHigh Trading VolumeLNSRLENSAR0.7225 of 5 stars$8.06-2.3%$8.00-0.7%+120.7%$93.62M$48.87M-5.52110Positive NewsMLSSMilestone Scientific0.7286 of 5 stars$1.08-8.5%$1.25+15.7%+96.7%$84.12M$8.88M-15.4330MGRMMonogram Orthopaedics3.5221 of 5 stars$2.45-2.0%$4.00+63.3%-21.6%$84.06M$364,999.00-5.2128Short Interest ↓Positive NewsEDAPEdap Tms3.4191 of 5 stars$2.07-1.4%$19.00+817.9%-63.8%$76.81M$63.41M-3.18307Short Interest ↓HYPRHyperfine1.9909 of 5 stars$0.98+4.3%$1.60+63.3%+2.0%$71.49M$13.26M-1.72190Positive NewsGap Up Related Companies and Tools Related Companies TELA Bio Alternatives Sensus Healthcare Alternatives electroCore Alternatives FONAR Alternatives Fractyl Health Alternatives LENSAR Alternatives Milestone Scientific Alternatives Monogram Orthopaedics Alternatives Edap Tms Alternatives Hyperfine Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXL) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXL Stock Alerts